Active NIH COVID-19 Funding & Collaboration Opportunities
The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) is a public private partnership to develop a coordinated research strategy of prioritizing and speeding development of the most promising vaccines and treatments.
The National Institutes of Health (NIH) COVID-19 Candidate and Technologies Portal collects data on diagnostic, vaccine, and other candidates or technologies with near-term potential for testing against COVID-19, as well as other information that could be leveraged in the response to COVID-19. This portal assists NIH in developing an inventory of information with the potential to aid in preventing or mitigating SARS-CoV-2 infection.
In December 2019, an outbreak of COVID-19, caused by the novel coronavirus known as SARS-CoV-2, was detected in mainland China. Researchers have been tracking the spread of the virus , mobilizing to speed innovative diagnostics, establishing treatment guidelines and working on a number of vaccines to protect against COVID-19 .
The National Institute of Allergy and Infectious Diseases (NIAID) leads NIH COVID-19 clinical research, and NIH research to develop therapeutics and vaccines for coronaviruses.
Fogarty grantees, trainees and fellows across geographic areas and research disciplines are helping to lead and support COVID-19 response efforts and research activities in some low-resource countries and regions.